Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors | Translational Psychiatry
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation | Journal of Medicinal Chemistry
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants. - Abstract - Europe PMC
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo | PNAS
MAGL-IN-4 | MAGL Inhibitor | MedChemExpress
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders | Journal of Medicinal Chemistry
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Synthesis and biological evaluation of novel tanshinone IIA derivatives for treating pain
APExBIO - MJN110 | MAGL inhibitor | CAS# 1438416-21-7
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase (MAGL) as a promising therapeutic target - ScienceDirect
Pharmaceuticals | Free Full-Text | Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Representative small molecule MAGL inhibitors. | Download Scientific Diagram
Chem Soc Rev
Molecules | Free Full-Text | Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
APExBIO - Monoacylglycerol Lipase Inhibitor 21 inhibitor of monoacylglycerol lipase (MAGL) and FAAH | CAS# 1643657-35-5
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C4CS00047A
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
A Schematic model of the effects of MAGL inhibition on the interactions... | Download Scientific Diagram
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download Scientific Diagram
Anticancer Potential of Small‐Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase - Jaiswal - 2021 - ChemMedChem - Wiley Online Library
